Nature Communications (Apr 2023)
MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
Abstract
Liver cirrhosis is characterised by extensive fibrosis of the liver, and understanding the underpinning immunological processes is important in designing intervention. Here authors show that Mucosal-Associated Invariant T cells are instrumental to controlling the balance between profibrogenic and restorative macrophages and inhibiting their activation might reverse liver fibrosis.